Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover Design

NCT01945359 · clinicaltrials.gov ↗

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis

Sponsor

Rocky Mountain MS Research Group, LLC

Collaborators

[object Object]